Microtube Array Membrane (MTAM) based Hollow Fiber Assay (HFA)- Anti-cancer drug screening solution for personalized medicine and preclinical drug development.
Based on the hollow fiber assay developed by the US National Cancer Institute (NCI), and combined with the novel Microtube Array Membrane delivers anti-cancer drug solutions for personalized cancer treatment and commercial anti-cancer drug R&D; capable of being applied to a wide range of anti-cancer drugs including Immuno-Checkpoint Blockers (ICBs) under combination therapy settings
Our screening range of services brings unprecedented accuracy and translatability, at a fraction of the time and cost of conventional screening solutions.
Media coverage of MTAM-HFA
Ready to find out more?
Drop us a message for customized solutions that fits your needs